Trends in survival of patients diagnosed with cancers of the brain and nervous system, thyroid, eye, bone, and soft tissues in the Nordic countries 1964-2003 followed up until the end of 2006
- PMID: 20192877
- DOI: 10.3109/02841861003610200
Trends in survival of patients diagnosed with cancers of the brain and nervous system, thyroid, eye, bone, and soft tissues in the Nordic countries 1964-2003 followed up until the end of 2006
Abstract
Background: Diagnoses of cancer of the brain, thyroid, eye, bone, and soft tissues are categorised by heterogeneity in disease frequency, survival, aetiology and prospects for curative therapy. In this paper, temporal trends in patient survival in the Nordic countries are considered.
Material and methods: Age-standardised incidence and mortality rates, 5-year relative survival, and excess mortality rates for varying follow-up periods are presented, as are age-specific 5-year relative survival by country, sex and 5-year diagnostic period.
Results: Brain cancer incidence rates have been rising but mortality has been relatively stable, with 5-year survival uniformly increasing from the early-1970s, particularly in younger patients. Five-year survival from brain cancer among men varies between 45% and 50% for men and 60% to 70% in women, with excess deaths decreasing with time in each of the Nordic populations. Age-standardised incidence rates of thyroid cancer have been mainly increasing during the 1960s and 1970s, although trends thereafter diverge, with 5-year relative survival increasing 20-30 percentage points over the last 40 years to around 80-90%. Thyroid cancer survival is consistently lower in Denmark, particularly in patients diagnosed aged over 60, while there is less geographic variation in excess deaths three months beyond initial diagnosis. Relative survival from eye cancer increased with time from approximately 60% in 1964-1968 to 80% 1999-2003, while for bone sarcoma, incidence rates remained stable, mortality rates declined, and 5-year survival increased slightly to around 55-65%. Soft tissue sarcoma incidence and survival have been slowly increasing since the 1960s, with little variation in survival (around 65%) for the most recent period.
Conclusions: There have been some notable changes in survival that can be linked to epidemiological and clinical factors in different countries over time. Time-varying proportions of the major histological subtypes might however have affected the survival estimates for a number of the cancer forms reviewed here.
Similar articles
-
Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006.Acta Oncol. 2010 Jun;49(5):644-54. doi: 10.3109/02841860903575315. Acta Oncol. 2010. PMID: 20151937
-
Survival of Danish cancer patients 1943-1987. Eye, brain and nervous system, thyroid, bone and connective tissue.APMIS Suppl. 1993;33:156-82. APMIS Suppl. 1993. PMID: 8512738
-
Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964-2003 followed up to the end of 2006.Acta Oncol. 2010 Jun;49(5):624-31. doi: 10.3109/02841860903575323. Acta Oncol. 2010. PMID: 20429724
-
Prediction of cancer incidence in the Nordic countries up to the year 2020.Eur J Cancer Prev. 2002 Jun;11 Suppl 1:S1-96. Eur J Cancer Prev. 2002. PMID: 12442806 Review. No abstract available.
-
Ovarian and endometrial cancers.Cancer Surv. 1994;19-20:287-307. Cancer Surv. 1994. PMID: 7895220 Review.
Cited by
-
Improved prognosis in soft-tissue sarcoma of extremity and trunk wall.Acta Orthop. 2017 Feb;88(1):116-120. doi: 10.1080/17453674.2016.1196429. Epub 2016 Jun 20. Acta Orthop. 2017. PMID: 27321676 Free PMC article.
-
Cancers of the brain and CNS: global patterns and trends in incidence.Neuro Oncol. 2017 Feb 1;19(2):270-280. doi: 10.1093/neuonc/now166. Neuro Oncol. 2017. PMID: 27571887 Free PMC article.
-
Disease burden, risk factors, and trends of primary central nervous system (CNS) cancer: A global study of registries data.Neuro Oncol. 2023 May 4;25(5):995-1005. doi: 10.1093/neuonc/noac213. Neuro Oncol. 2023. PMID: 36048182 Free PMC article.
-
Incidence, Mortality, and Survival Trends of Primary CNS Tumors in Cali, Colombia, From 1962 to 2019.JCO Glob Oncol. 2020 Nov;6:1712-1720. doi: 10.1200/GO.20.00368. JCO Glob Oncol. 2020. PMID: 33156716 Free PMC article.
-
Have the recent advancements in cancer therapy and survival benefitted patients of all age groups across the Nordic countries? NORDCAN survival analyses 2002-2021.Acta Oncol. 2024 Apr 10;63:179-191. doi: 10.2340/1651-226X.2024.35094. Acta Oncol. 2024. PMID: 38597666 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical